News
CMS proposed rules - directionally positive
Maria Karlsson Osipova
2026-07-16
16:50 CEST
CMS has released its CY 2027 proposed rules for MPFS and OPPS. We think CMS has moved in the right direction structurally, but not yet in terms of meaningful economic substance.
On the Medicare Physician Fee Schedule (MPFS) side, CMS did not propose to revalue the scalp-cooling CPT codes, noting that the August 2024 Time and Motion Study had already been considered in setting the CY 2026 rates. The agency does not believe the codes are misvalued but is inviting public comment ahead of the final rule. In a press release, Paxman stated that MPFS payments are set to decline slightly due to broader fee schedule changes. On the Outpatient Prospective Payment System (OPPS) side, CPT 97008 (cap placement and pre-cooling) is newly assigned a separate payment rate of USD35.5 per session.
What does it mean? In November 2025, we wrote that unbundling under OPPS would have been a clear positive following the CY 2026 final rule, which kept 97008 and 97009 bundled. The CY 2027 OPPS proposed rule delivered the unbundling, but not yet in meaningful economic substance. At USD35.5 per session, 97008 generates cUSD213 in additional OPPS revenue across a six-session course, bringing the total per-patient value to USD1,663.5, as we understand it.
Our view. We see the CY 2027 proposed rules as a directionally positive outcome. The partial unbundling of 97008 under OPPS is a step in the right direction, in our view, and shows that CMS is gradually moving towards separately reimbursing each component of scalp cooling. The comment period will be important to follow; Paxman is set to submit comments and continue engaging with CMS ahead of the final rules. We also believe Paxman is now better positioned to engage with CMS than during the CY 2026 cycle, supported by live Category I codes and growing real-world claims data from IBBM sites. We believe the structural story remains intact, supported by permanent CPT codes, expanding state mandates and a largely commercially insured patient base (Medicare/Medicaid representing only c15–20% of patients). The CY 2027 final rule is the next milestone, which we expect to be published in November 2026. The Q2 report is due on 21 August; we have not yet published a preview.